C.H. Robinson Worldwide is one of the largest third-party logistics (3PL) providers globally, specializing in non-asset-based freight brokerage, transportation management, and supply chain solutions. The company connects approximately 75,000 customers with a network of roughly 450,000 contract carriers, managing 37 million shipments and $23 billion in freight annually. Its core North American Surface Transportation (NAST) segment accounts for roughly three-quarters of revenue, complemented by a growing Global Forwarding division covering air and ocean freight. The company's Lean AI strategy has driven significant productivity gains, automating shipment pricing, carrier matching, and cargo monitoring. Investors track CHRW closely as a bellwether for freight demand, industrial activity, and broader macroeconomic health. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, CHRW shares plunged from $193.50 on July 10 to $149.35 as of the August 7 close — a decline of approximately 22.8%. The selloff was concentrated in two waves: an initial 9.3% drop on July 24 following news of the Texas nuclear verdict, and a massive 15.4% single-day collapse on July 30 after the Q2 earnings report and conference call. The quarterly trend tells a similarly turbulent story. From mid-May levels around $170, the stock rallied to an all-time 52-week high of $210.33 before the dual shocks of legal liability and cautious guidance erased those gains and pushed shares well below their starting point for the quarter.
The single largest catalyst was the July 23 jury verdict in Lipe v. Lupus Superior, which handed down approximately $604 million in damages against C.H. Robinson and co-defendants. As the first major trial outcome since the U.S. Supreme Court's Montgomery v. Caribe Transport II ruling in May 2026 — which stripped away federal preemption protections for freight brokers — the decision sent shockwaves through the 3PL industry. The jury found C.H. Robinson 23% responsible and controversially determined the carrier's driver was effectively a "borrowed employee" of the broker. The verdict triggered an immediate selloff not only in CHRW but also in peers like RXO and LSTR.
Days later, the Q2 2026 earnings report on July 29 deepened the rout. While adjusted EPS of $1.61 beat consensus estimates of $1.53 and revenue surged 19.3% to $4.93 billion, management warned of decelerating industry volume growth — revising its outlook to a range of -3% to +1% from a prior flat-to-5% growth expectation. This effectively signaled that full-year adjusted EPS could land around $6.00, below the $6.20 consensus. Compounding concerns, operating cash flow collapsed to $35.9 million from $227.1 million a year earlier, driven by a $227.3 million adverse swing in net working capital tied to higher freight rates. Citigroup had already downgraded the stock to Neutral on June 15, flagging valuation risk when shares traded near $199. From what I see, this combination of legal and operational signals created a perfect storm for the pullback.
The broader quarterly narrative is one of a sharp boom-to-bust cycle. CHRW rallied strongly through late spring and early summer, driven by tightening truckload capacity, firmer spot rates, enthusiasm around AI-driven margin expansion, and multiple analyst price target increases. Stifel raised its target to $215, Wells Fargo to $215, and Baird set a $230 target. The stock hit $210.33 on July 21 — a 52-week high and a gain of roughly 24% from mid-May lows. However, the rally was built on a stretched valuation exceeding 42 times forward earnings, leaving no cushion when negative catalysts emerged. The Montgomery ruling in May had already planted seeds of legal risk, and the Texas verdict crystallized those fears. By the time Q2 results landed, the combination of legal overhang, cautious guidance, and deteriorating cash generation was too much for the elevated multiple to sustain, reversing nearly all the quarter's gains in a matter of days.
The most critical factor for CHRW going forward is the trajectory of the Lipe v. Lupus Superior appeal. CEO Dave Bozeman has expressed confidence that the verdict will be overturned or significantly reduced on appeal, but the process could take years, leaving lingering uncertainty around potential financial exposure, insurance coverage, and broader industry precedent. Investors should also monitor any regulatory or legislative responses — particularly whether the FMCSA or Congress moves to establish clearer carrier selection standards for brokers. On the operational side, freight demand trends, spot rate movements, and the company's ability to sustain its mid-cycle margin targets through Lean AI productivity gains will be closely watched. The next earnings report, expected in early November, will be pivotal in assessing whether the volume deceleration warning was conservative or the start of a deeper freight slowdown. Additionally, the Deutsche Bank Industrials Summit appearance on August 11 may provide incremental clarity on management's strategic outlook. I’m watching this closely as the appeal process unfolds.
In periods of heightened volatility like the one surrounding CHRW, I often review Tickeron’s Trending AI Robots to see how automated strategies are performing across thousands of stocks. These bots use a range of approaches, from swing trading to longer-term trend following, and only the top-performing options appear in the curated list. It offers a practical way to explore data-driven positioning in real time without replacing my own analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for CHRW turned positive on August 20, 2026. Looking at past instances where CHRW's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CHRW's RSI Indicator exited the oversold zone, 13 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on August 26, 2026. You may want to consider a long position or call options on CHRW as a result. In 67 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
Following a +3.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRW advanced for three days, in 244 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 140 of 249 cases where CHRW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 57 cases where CHRW's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 51%.
The 50-day moving average for CHRW moved below the 200-day moving average on August 28, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
CHRW broke above its upper Bollinger Band on September 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CHRW's P/B Ratio (10.989) is slightly higher than the industry average of (3.763). P/E Ratio (29.197) is within average values for comparable stocks, (223.263). Projected Growth (PEG Ratio) (1.863) is also within normal values, averaging (5.156). Dividend Yield (0.016) settles around the average of (0.013) among similar stocks. P/S Ratio (1.095) is also within normal values, averaging (2.034).
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. CHRW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of multimodal transportation services and logistics solutions
Industry OtherTransportation